United States Antimony Corporation reported $36M of revenue over the trailing twelve months, +42% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $36M (to Q2 2026). Net income: −$16M, trailing twelve months to Q2 2026. Free cash flow: −$71M, trailing twelve months to Q2 2026. Operating margin: −71%, trailing twelve months to Q2 2026.

UAMYUnited States Antimony Corporation

Basic Materials

$3.05-76% 1Y

$3.05

$2.7752 weeks$13.43

UAMY as reported

United States Antimony Corporation reported $36M of revenue over the trailing twelve months, +42% on the year before. 10 reported series are charted on this page, each one as filed.

$36M

Revenue, trailing twelve months · to Q2 2026 · +42% against the twelve months before

Net income: −$16M
Net income · +1742% year on year · trailing twelve months to Q2 2026
Free cash flow: −$71M
Free cash flow · +744% year on year · trailing twelve months to Q2 2026
Operating margin: −71%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for UAMY, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$36M	+42%	Q2 2026
Net income	−$16M	+1742%	Q2 2026
EPS	−$0.13	+1200%	Q2 2026
Gross margin	17%	n/a	Q2 2026
Operating margin	−71%	n/a	Q2 2026
Net margin	−56%	n/a	Q2 2026
ROE	−7.8%	n/a	Q2 2026
ROA	−7.1%	n/a	Q2 2026
ROIC	−9.7%	n/a	Q2 2026
Free cash flow	−$71M	+744%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.